Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
9.08
-2.08 (-18.64%)
At close: Nov 13, 2026, 4:00 PM EST
9.02
-0.06 (-0.66%)
Pre-market: Nov 16, 2026, 7:09 AM EST

Zevra Therapeutics Revenue

Zevra Therapeutics had revenue of $37.76M in the quarter ending September 30, 2026, with 44.86% growth. This brings the company's total for the last twelve months to $147.76M, up 75.10% year-over-year. In the year 2025, Zevra Therapeutics had annual revenue of $106.47M with 350.91% growth. That makes Zevra Therapeutics the 19,753rd largest company in the world by revenue and 3,058th in the United States.

Revenue (ttm)
$147.76M
Revenue Growth
+75.10%
P/S Ratio
3.66
Revenue / Employee
$2,422,361
Employees
61
Market Cap
540.30M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025106.47M82.86M350.91%
Dec 31, 202423.61M-3.85M-14.02%
Dec 31, 202327.46M17.00M162.58%
Dec 31, 202210.46M-18.19M-63.50%
Dec 31, 202128.65M15.36M115.61%
Dec 31, 202013.29M449.00K3.50%
Dec 31, 201912.84M--
Dec 31, 2018---
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Valneva SE163.30M
REGENXBIO153.91M
Orchestra BioMed Holdings31.21M
Crescent Biopharma15.00M
Capricor Therapeutics11.13M
Surrozen10.53M
Neurogene925.00K
Entera Bio42.00K
Revenue Rankings